Topiramate (Topamax): safety review triggered by study reporting increased risk of neurodevelopmental disabilities with prenatal exposure

[helvella]

If you have any interest or concerns, please follow the link.

Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure

We have initiated a new safety review into topiramate as a result of an observational study reporting an increased risk of neurodevelopmental disabilities in children whose mothers took topiramate during pregnancy. Topiramate is known to be associated with an increased risk of congenital malformations and effects on fetal growth if used during pregnancy. Continue to counsel patients who can become pregnant on the known and emerging risks of topiramate for an unborn baby and on the need to use effective contraception throughout use.

gov.uk/drug-safety-update/t...

This is off-topic for this forum but, potentially, of great significance. It is not intended to start a discussion about Topiramate and its use.

For that reason, I shall be closing this post to replies.